Charge Density and Electrostatic Interactions of Fidarestat, an Inhibitor of Human Aldose Reductase

被引:52
作者
Fournier, Bertrand [1 ]
Bendeif, El-Eulmi [1 ]
Guillot, Benoit [1 ]
Podjarny, Alberto [2 ]
Lecomte, Claude [1 ]
Jelsch, Christian [1 ]
机构
[1] Univ Nancy, Lab Cristallog Resonance Magnet & Modelisat, Inst Jean Barriol, Fac Sci & Tech,CNRS,UMR 7036, F-54506 Vandoeuvre Les Nancy, France
[2] IGBMC, Dept Struct Biol & Genom, CNRS INSERM UDS, F-67404 Illkirch Graffenstaden, France
关键词
RESOLUTION DRUG DESIGN; GRAPH-SET ANALYSIS; X-RAY; TOPOLOGICAL ANALYSIS; SMALL-MOLECULE; ABSOLUTE-CONFIGURATION; CRYSTAL-STRUCTURES; DIFFRACTION DATA; HYDROGEN-BONDS; COMPLEX;
D O I
10.1021/ja8095015
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The charge density and the topological features of fidarestat, an inhibitor of human aldose reductase, have been determined from ultra high-resolution X-ray diffraction data at 100 K. The modeled electron density was used to calculate the electrostatic interaction energy of fidarestat and its (2R,4S) stereoisomer with the human aldose reductase by using the ELMAM database as coded in the MoPro program. Such calculation may be extended to other protein complexes for which accurate high resolution X-ray data are available. The paper also discusses the hydrogen bonds in the fidarestat crystal. There are notably two hydrogen bonds with a pi system as an acceptor. All the chemical bonds and the intermolecular interactions, especially these two pi center dot center dot center dot H bonds, have been quantitatively studied by topological analysis. The three-dimensional electrostatic potential calculated on the molecular surface emphasizes the preferential polar binding sites of fidarestat. Theses interacting features in the molecule are crucial for drug-receptor recognition. The interactions between chemical groups in the crystal are also analyzed by computing the electrostatic energy using the latest advancements of the MoPro crystallographic software. The complexes of fidarestat and its (2R,4S) stereoisomer with human aldose reductase were modeled with a multipolar atom model transferred from our experimental electron density database. Accurate estimation of electrostatic interaction energy between inhibitors and the main residues of the protein active site is derived from this high detail level of the electron density.
引用
收藏
页码:10929 / 10941
页数:13
相关论文
共 70 条
[31]   Atoms in crystals - From experimental charge densities [J].
Flensburg, C ;
Madsen, D .
ACTA CRYSTALLOGRAPHICA SECTION A, 2000, 56 :24-28
[32]   Experimental and theoretical electron density studies in large molecules:: NAD+, β-nicotinamide adenine dinucleotide [J].
Guillot, B ;
Muzet, N ;
Artacho, E ;
Lecomte, C ;
Jelsch, C .
JOURNAL OF PHYSICAL CHEMISTRY B, 2003, 107 (34) :9109-9121
[33]   Refinement of proteins at subatomic resolution with MOPRO [J].
Guillot, B ;
Viry, L ;
Guillot, R ;
Lecomte, C ;
Jelsch, C .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 2001, 34 :214-223
[34]   Charge-density analysis of a protein structure at subatomic resolution: the human aldose reductase case [J].
Guillot, Benoit ;
Jelsch, Christian ;
Podjarny, Alberto ;
Lecomte, Claude .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2008, 64 :567-588
[35]   ELECTRON POPULATION ANALYSIS OF ACCURATE DIFFRACTION DATA .6. TESTING ASPHERICAL ATOM REFINEMENTS ON SMALL-MOLECULE DATA SETS [J].
HANSEN, NK ;
COPPENS, P .
ACTA CRYSTALLOGRAPHICA SECTION A, 1978, 34 (NOV) :909-921
[36]   STRUCTURAL CONSEQUENCES OF A MOLECULAR ASSEMBLY THAT IS DEFICIENT IN HYDROGEN-BOND ACCEPTORS [J].
HANTON, LR ;
HUNTER, CA ;
PURVIS, DH .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1992, (16) :1134-1136
[37]   Experimental and theoretical charge density studies of tetrafluorophthalonitrile and tetrafluoroisophthalonitrile [J].
Hibbs, DE ;
Overgaard, J ;
Platts, JA ;
Waller, MP ;
Hursthouse, MB .
JOURNAL OF PHYSICAL CHEMISTRY B, 2004, 108 (11) :3663-3672
[38]   CAN X-RAY DATA DISTINGUISH BONDING EFFECTS FROM VIBRATIONAL SMEARING [J].
HIRSHFELD, FL .
ACTA CRYSTALLOGRAPHICA SECTION A, 1976, 32 (MAR1) :239-244
[39]   Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy - A 52-week multicenter placebo-controlled double-blind parallel group study [J].
Hotta, N ;
Toyota, T ;
Matsuoka, K ;
Shigeta, Y ;
Kikkawa, R ;
Kaneko, T ;
Takahashi, A ;
Sugimura, K ;
Koike, Y ;
Ishii, J ;
Sakamoto, N .
DIABETES CARE, 2001, 24 (10) :1776-1782
[40]   Ultrahigh resolution drug design I:: Details of interactions in human aldose reductase-inhibitor complex at 0.66 Å [J].
Howard, EI ;
Sanishvili, R ;
Cachau, RE ;
Mitschler, A ;
Chevrier, B ;
Barth, P ;
Lamour, V ;
Van Zandt, M ;
Sibley, E ;
Bon, C ;
Moras, D ;
Schneider, TR ;
Joachimiak, A ;
Podjarny, A .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2004, 55 (04) :792-804